| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.RHU.0000166626.68898.17 |
| P698 | PubMed publication ID | 16357751 |
| P2093 | author name string | Joel M Kremer | |
| P2860 | cites work | CTLA-4 can function as a negative regulator of T cell activation | Q28235866 |
| P433 | issue | 3 Suppl | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | S55-62 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Journal of Clinical Rheumatology | Q15766312 |
| P1476 | title | Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis | |
| P478 | volume | 11 |
| Q36593078 | Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists |
| Q37032656 | Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis |
| Q53394501 | Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica. |
| Q43711793 | B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice. |
| Q42249555 | B cells as a target of immune modulation |
| Q37701273 | Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis |
| Q35138666 | Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patients |
| Q38070582 | Experimental advances in understanding allergic airway inflammation |
| Q37786627 | Golimumab: a new anti-TNF-α agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis |
| Q44395826 | QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy |
| Q41176187 | Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides |
| Q36869567 | Update on abatacept: a selective costimulation modulator for rheumatoid arthritis |
| Q52885796 | [Personalized medicine for rheumatoid arthritis : serological and clinical patient profiles to optimize B and T cell targeted therapy]. |
Search more.